Edward Andrle is General Manager, Neuromodulation at LivaNova. Previously, Andrle served as Senior Vice President of New Ventures and Business Development for LivaNova, and was Vice President of Strategy and Business Development at Sorin Group for five years prior to that. Andrle had a successful career in the medical device industry, where he also became an entrepreneur and a CEO of start-up companies like Teramed (endovascular stent-graft), Myocor (mitral valve surgery) and StarFire Medical (neurovascular technology). Prior to this Andrle spent 5 years as a Vice President at Boston Scientific, where he led a new business unit focused on peripheral vascular catheters and guidewires that accounted for over $100 million in sales. He holds an MBA from the Stanford Graduate School of Business and a BS in Chemical engineering from the University of Notre Dame. Edward Andrle is General Manager, Neuromodulation at LivaNova. Previously, Andrle served as Senior Vice President of New Ventures and Business Development for LivaNova, and was Vice President of Strategy and Business Development at Sorin Group for five years prior to that. Andrle had a successful career in the medical device industry, where he also became an entrepreneur and a CEO of start-up companies like Teramed (endovascular stent-graft), Myocor (mitral valve surgery) and StarFire Medical (neurovascular technology). Prior to this Andrle spent 5 years as a Vice President at Boston Scientific, where he led a new business unit focused on peripheral vascular catheters and guidewires that accounted for over $100 million in sales. He holds an MBA from the Stanford Graduate School of Business and a BS in Chemical engineering from the University of Notre Dame.

fermentation